𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease

✍ Scribed by Angelo Antonini; Chiara Siri; Gabriella Santangelo; Roberto Cilia; Michele Poletti; Margherita Canesi; Alessandra Caporali; Francesca Mancini; Gianni Pezzoli; Roberto Ceravolo; Ubaldo Bonuccelli; Paolo Barone


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
110 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background:

Abnormal repetitive behaviors have been reported in Parkinson's disease (PD) during dopamine replacement therapy (DRT) and associated with individual predisposing features, including impulsivity. However, impulsivity and compulsive symptoms have never been explored in PD patients before initiation of DRT. We previously reported a 20% of impulse control disorders (ICD) in an Italian cohort.

Methods:

103 consecutive newly diagnosed drug‐naïve PD patients (means: age = 60.5 ± 9.2 years; duration = 15.4 ± 15.3 months) were screened for compulsive sexual behavior, compulsive buying, intermittent explosive disorder (Minnesota Impulsive Disorders Interview, MIDI), and pathological gambling (South Oaks Gambling Screen, SOGS). Barratt Impulsiveness Scale (BIS‐11) and Maudsley Obsessional‐Compulsive Questionnaire (MOCQ/R) assessed impulsivity, obsessive‐compulsive symptoms, respectively. Depression (GDS‐15) and general cognitive status were additionally assessed. We also compared ICDs frequency with our healthy controls.

Results:

17.5% of PD patients screened positive for at least one ICD at MIDI (17/103) and SOGS (1/103), though none had a disorder based on DSM‐IV criteria. These frequencies were similar to healthy controls. There was a trend toward higher scores in BIS‐11 attentive‐impulsivity subscale (15.2 ± 4.8 vs. 18.7 ± 4.9; P = 0.007) and in MOCQ/R‐Doubting subscale (0.67 ± 1.1 vs. 1.5 ± 1.2; P = 0.007) in PD with ICD. We also observed a positive correlation between GDS‐15 and BIS‐11.

Conclusions:

Similar to our healthy control population, we found a significant proportion of early PD patients positive for ICDs before starting treatment. We also found a relationship between impulsivity and depression. A detailed behavioral assessment before starting dopaminergic therapy is recommended. © 2011 Movement Disorder Society


📜 SIMILAR VOLUMES


Impulsive and compulsive behaviors in Pa
✍ Andrew H. Evans; Antonio P. Strafella; Daniel Weintraub; Mark Stacy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract Antiparkinson therapy can be the primary cause of a range of nonmotor symptoms that include a set of complex disinhibitory psychomotor pathologies and are linked by their repetitive, reward or incentive‐based natures. These behaviors relate to aberrant or excessive dopamine receptor sti

Cognitive impulsivity in Parkinson's dis
✍ Gabriel Robert; Dominique Drapier; Marc Verin; Bruno Millet; Jean-Philippe Azula 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Impulsivity may be induced by therapeutic interventions (dopamine replacement therapies and sub‐thalamic nucleus (STN) stimulation) in patients with Parkinson's disease (PD). The present review has two goals. First, to describe the most frequently encountered facets of cognitive impulsi

Cognitive-nigrostriatal relationships in
✍ Flavio Nobili; Claudio Campus; Dario Arnaldi; Fabrizio De Carli; Gaia Cabassi; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract To unveil cognitive‐nigrostriatal correlations in Parkinson's disease (PD), 30 de novo, drug‐naïve PD patients and 15 patients with essential tremor (Controls, CTR) underwent a neuropsychological (NPS) battery and brain SPECT with [I‐123]Ioflupane, as a biomarker of nigrostriatal functi

Motor behavior abnormalities in drug-naï
✍ Victor Peralta; Maria S. Campos; Elena García De Jalón; Manuel J. Cuesta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐

Risk and learning in impulsive and nonim
✍ Atbin Djamshidian; Ashwani Jha; Sean S. O'Sullivan; Laura Silveira-Moriyama; Cla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the res

The relation between cognition and motor
✍ Magdalena Eriksson Domellöf; Eva Elgh; Lars Forsgren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract Recent studies have reported cognitive decline to be common in the early phase of Parkinson's disease. Imaging data connect working memory and executive functioning to the dopamine system. It has also been suggested that bradykinesia is the clinical manifestation most closely related to